Compare AUTL & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUTL | DXYZ |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United Kingdom | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 385.9M | 1.3B |
| IPO Year | 2025 | 2021 |
| Metric | AUTL | DXYZ |
|---|---|---|
| Price | $1.53 | $22.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 947.5K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,120,000.00 | N/A |
| Revenue This Year | $80.32 | N/A |
| Revenue Next Year | $53.96 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.18 | $19.71 |
| 52 Week High | $2.52 | $72.87 |
| Indicator | AUTL | DXYZ |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | 32.85 |
| Support Level | $1.37 | $19.71 |
| Resistance Level | $1.52 | $29.56 |
| Average True Range (ATR) | 0.09 | 1.49 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 25.00 | 2.37 |
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It is designed to be an investment portfolio of the Top 100 High-Growth Tech Companies.